La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « Cell Survival »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Cell Size < Cell Survival < Cell Transformation, Neoplastic  Facettes :

List of bibliographic references indexed by Cell Survival

Number of relevant bibliographic references: 37.
[0-20] [0 - 20][0 - 37][20-36][20-40]
Ident.Authors (with country if any)Title
000016 (2017) P Githure M'Angale [Canada] ; Brian E. Staveley [Canada]The HtrA2 Drosophila model of Parkinson's disease is suppressed by the pro-survival Bcl-2 Buffy.
000051 (2017) P Githure M'Angale [Canada] ; Brian E. Staveley [Canada]Overexpression of Buffy enhances the loss of parkin and suppresses the loss of Pink1 phenotypes in Drosophila.
000153 (2016) Qing He [République populaire de Chine] ; James B. Koprich [Canada] ; Ying Wang [République populaire de Chine] ; Wen-Bo Yu [République populaire de Chine] ; Bao-Guo Xiao [République populaire de Chine] ; Jonathan M. Brotchie [Canada] ; Jian Wang [République populaire de Chine]Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease.
000815 (2015) Dianbo Qu ; Ali Hage ; Katie Don-Carolis ; En Huang ; Alvin Joselin ; Farzaneh Safarpour ; Paul C. Marcogliese ; Maxime W. C. Rousseaux ; Sarah J. Hewitt ; Tianwen Huang ; Doo-Soon Im ; Steve Callaghan ; Danielle Dewar-Darch [Canada] ; Daniel Figeys [Canada] ; Ruth S. Slack ; David S. ParkBAG2 Gene-mediated Regulation of PINK1 Protein Is Critical for Mitochondrial Translocation of PARKIN and Neuronal Survival*
000987 (2014) Krithika Muthukumaran [Canada] ; Samantha Leahy [Canada] ; Kate Harrison [Canada] ; Marianna Sikorska [Canada] ; Jagdeep K. Sandhu [Canada] ; Jerome Cohen [Canada] ; Corrine Keshan [Canada] ; Daniel Lopatin [Canada] ; Harvey Miller [Canada] ; Henryk Borowy-Borowski [Canada] ; Patricia Lanthier [Canada] ; Shelly Weinstock [États-Unis] ; Siyaram Pandey [Canada]Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson’s disease
000A55 (2014) Jocelyn M. Madeira [Canada] ; Ekta Bajwa [Canada] ; Maegan J. Stuart [Canada] ; Sadayuki Hashioka [Japon] ; Andis Klegeris [Canada]Gold drug auranofin could reduce neuroinflammation by inhibiting microglia cytotoxic secretions and primed respiratory burst.
000B10 (2014) Mohammad Parsanejad [Canada] ; Noam Bourquard [États-Unis] ; Dianbo Qu [Canada] ; Yi Zhang [Canada] ; En Huang [Canada] ; Maxime W. C. Rousseaux [Canada, États-Unis] ; Hossein Aleyasin [Canada, États-Unis] ; Isabella Irrcher [Canada] ; Steve Callaghan [Canada] ; Dominique C. Vaillant [Canada] ; Raymond H. Kim [Canada] ; Ruth S. Slack [Canada] ; Tak W. Mak [Canada] ; Srinivasa T. Reddy [États-Unis] ; Daniel Figeys [Canada] ; David S. Park [Canada, Corée du Sud]DJ-1 Interacts with and Regulates Paraoxonase-2, an Enzyme Critical for Neuronal Survival in Response to Oxidative Stress
000C37 (2013) Kelvin C. Luk [Canada] ; Vladimir V. Rymar ; Pepijn Van Den Munckhof ; Stefan Nicolau ; Claude Steriade ; Panojot Bifsha ; Jacques Drouin ; Abbas F. SadikotThe transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to neurodegenerative stress.
000D07 (2013) Susanna Ekholm-Reed ; Matthew S. Goldberg ; Michael G. Schlossmacher ; Steven I. ReedParkin-Dependent Degradation of the F-Box Protein Fbw7β Promotes Neuronal Survival in Response to Oxidative Stress by Stabilizing Mcl-1
000E30 (2013) Zhizhi Sun [Canada] ; Vinith Yathindranath ; Matthew Worden ; James A. Thliveris ; Stephanie Chu ; Fiona E. Parkinson ; Torsten Hegmann ; Donald W. MillerCharacterization of cellular uptake and toxicity of aminosilane-coated iron oxide nanoparticles with different charges in central nervous system-relevant cell culture models.
001164 (2012) Daniel Hernandez-Baltazar [Mexique] ; Daniel Martinez-Fong [Mexique] ; Louis-Eric Trudeau [Canada]Optimizing NTS-Polyplex as a Tool for Gene Transfer to Cultured Dopamine Neurons
001690 (2011) C J Yong-Kee [Canada] ; D. Salomonczyk ; J E NashDevelopment and validation of a screening assay for the evaluation of putative neuroprotective agents in the treatment of Parkinson's disease.
001982 (2010) Daryl J. Fediuk [Canada] ; Tao Wang ; Joshua E. Raizman ; Fiona E. Parkinson ; Xiaochen GuTissue deposition of the insect repellent DEET and the sunscreen oxybenzone from repeated topical skin applications in rats.
001C17 (2010) Moonhee Lee [Canada] ; Anna Sparatore [Italie] ; Piero Del Soldato [Italie] ; Edith Mcgeer [Canada] ; Patrick L. Mcgeer [Canada]Hydrogen sulfide‐releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation
001D99 (2009) Isabella Irrcher [Canada] ; David S. ParkParkinson's disease: to live or die by autophagy.
001E31 (2009) Sadayuki Hashioka ; Andis Klegeris ; Claudia Schwab ; Patrick L. McgeerInterferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells.
002139 (2008) Karim Mukhida [Canada] ; Behnam A. Baghbaderani ; Murray Hong ; Matthew Lewington ; Timothy Phillips ; Marcus Mcleod ; Arindom Sen ; Leo A. Behie ; Ivar MendezSurvival, differentiation, and migration of bioreactor-expanded human neural precursor cells in a model of Parkinson disease in rats.
002209 (2008) M. Emdadul Haque [Canada] ; Kelly J. Thomas [États-Unis] ; Cheryl D'Souza [Canada] ; Steve Callaghan [Canada] ; Tohru Kitada [États-Unis] ; Ruth S. Slack [Canada] ; Paul Fraser [Canada] ; Mark R. Cookson [États-Unis] ; Anurag Tandon [Canada] ; David S. Park [Canada]Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP
002358 (2008) M. Quinn [Canada] ; K. Mukhida [Canada] ; D. Sadi [Canada] ; M. Hong [Canada] ; I. MendezAdjunctive use of the non‐ionic surfactant Poloxamer  188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease
002693 (2007) Joseph Flores [Canada] ; Ivan L. Cepeda [Canada] ; Michael L. Comfeldt [États-Unis] ; John R. O'Kusky [Canada] ; Doris J. Doudet [Canada]Characterization and survival of long-term implants of human retinal pigment epithelial cells attached to gelatin microcarriers in a model of parkinson disease
002759 (2006) H. Ganjavi [Canada] ; M. Gee ; A. Narendran ; N. Parkinson ; M. Krishnamoorthy ; M H Freedman ; D. MalkinAdenovirus-mediated p53 gene therapy in osteosarcoma cell lines: sensitization to cisplatin and doxorubicin.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Cell Survival" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Cell Survival" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Cell Survival
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022